AI assistant
Sending…
DELUXE CORP — Director's Dealing 2017
Jan 27, 2017
32349_dirs_2017-01-26_af3fe538-9160-46ff-ac53-6a53b3230e96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DELUXE CORP (DLX)
CIK: 0000027996
Period of Report: 2017-01-24
Reporting Person: SCHRAM LEE J (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-24 | Common Stock | A | 18004 | — | Acquired | 296162 | Direct |
| 2017-01-24 | Comon Stock | F | 9382 | $73.63 | Disposed | 286780 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock Option | $25.59 | 2018-02-16 | Common Stock (54200) | 54200 | Direct |
| Common Stock Option | $25.45 | 2019-02-16 | Common Stock (106000) | 106000 | Direct |
| Common Stock Option | $38.80 | 2020-02-20 | Common Stock (95800) | 95800 | Direct |
| Common Stock Option | $50.32 | 2021-02-27 | Common Stock (64435) | 64435 | Direct |
| Common Stock Option | $67.08 | 2022-02-12 | Common Stock (64162) | 64162 | Direct |
| Common Stock Option | $54.30 | 2023-02-17 | Common Stock (127238) | 127238 | Direct |
Footnotes
F1: This award reflects the settlement of performance share units that were determined to vest based on the level of achievement of the specified performance targets.
F2: Total ownership includes 82,710 shares of restricted stock.
F3: Options vest in three equal installments on the three succeeding anniversary dates of the date of grant, provided the holder remains an employee of the Company. Date entered reflects date on which first installment vests(ed).
More from DELUXE CORP
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 6